ANI Pharmaceuticals Inc
NASDAQ:ANIP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
ANI Pharmaceuticals Inc
NASDAQ:ANIP
|
US |
|
A
|
Allegiant Professional Business Services Inc
OTC:APRO
|
US |
|
eXp World Holdings Inc
NASDAQ:EXPI
|
US |
|
Scansource Inc
NASDAQ:SCSC
|
US |
|
PubMatic Inc
NASDAQ:PUBM
|
US |
|
Selaras Citra Nusantara Perkasa Tbk PT
IDX:SCNP
|
ID |
|
Airtificial Intelligence Structures SA
F:IRG
|
ES |
|
Bank Negara Indonesia (Persero) Tbk PT
IDX:BBNI
|
ID |
|
TNG Ltd
ASX:TNG
|
AU |
Wall Street
Price Targets
ANIP Price Targets Summary
ANI Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
ANIP
is 112.2 USD
with a low forecast of 90.9 USD and a high forecast of 130.2 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ANIP's stock price target?
Price Target
112.2
USD
According to Wall Street analysts, the average 1-year price target for
ANIP
is 112.2 USD
with a low forecast of 90.9 USD and a high forecast of 130.2 USD.
What is ANI Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
15%
For the last 14 years the
compound annual growth rate for
ANI Pharmaceuticals Inc's revenue is
73%.
The projected
CAGR
for the next 3 years is
15%.
What is ANI Pharmaceuticals Inc's Operating Income forecast?
Projected CAGR
51%
The
compound annual growth rate
of ANI Pharmaceuticals Inc's operating income for the next 3 years is
51%.
What is ANI Pharmaceuticals Inc's Net Income forecast?
Projected CAGR
55%
The
compound annual growth rate
of ANI Pharmaceuticals Inc's net income for the next 3 years is
55%.
